Abstract
Approximately 5–15% of all dermatologic malignancies manifest in the upper and lower eyelids. The primary types include basal cell carcinoma, squamous cell carcinoma, and sebaceous cell carcinoma, with Merkel cell carcinoma and melanoma following closely behind. Basal cell carcinoma predominantly affects the lower eyelid, yet various other carcinomas, melanomas, metastases, and neoplasms of diverse origins can arise on both upper and lower eyelids. Risk factors such as advanced age, smoking, and notably, exposure to UV light significantly contribute to the development of these eyelid lesions. Despite the increasing incidence, research on dermatologic eyelid malignancies remains limited. However, such study is imperative given that many systemic oncologic malignancies initially present as metastatic eyelid lesions. This paper provides an in-depth exploration of eyelid anatomy, clinical presentation, diagnosis, and treatment management.
Key Points:
-
Eyelid metastases represent less than one percent of all eyelid cancers, yet they often serve as the initial indication of an underlying systemic malignancy.
-
Early detection and treatment is crucial in improving prognosis and quality of life for patients.
-
Treatment options encompass a range of modalities, with Mohs surgery as the gold standard for the removal of ocular tumors.
-
Additional treatment options include local excision as well as non-surgical interventions such as radiotherapy, cryotherapy, immunotherapy, and topical medications.
Similar content being viewed by others
References
Ciuciulete AR, Stepan AE, Andreiana BC, Simionescu CE (2022) Non-melanoma skin cancer: statistical associations between clinical parameters. Curr Health Sci J 48(1):110–115. https://doi.org/10.12865/CHSJ.48.01.16
Silverman NMD, Shinder R (2017) What’s New in Eyelid Tumors. Asia-Pacific Journal of Ophthalmology 6(2):143–152. https://doi.org/10.22608/APO.201701
Pe’er J (2016) Pathology of eyelid tumors. Indian J Ophthalmol 64(3):177–190. https://doi.org/10.4103/0301-4738.181752
ML Cochran MJ Lopez CN Czyz 2023Anatomy, Head and Neck: Eyelid [Updated 2023 Aug 14] In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
Lynde C, Gunton L, Weinberg T, Murray C (2014) Periorbital Surface Anatomy for the Dermatologist. J Cutan Med Surg 18(2):141–144. https://doi.org/10.2310/7750.2013.13135
B McDaniel T Badri RB Steele Basal Cell Carcinoma [Updated 2022 Sep 19]. In: StatPearls [Internet] Treasure Island (FL): StatPearls Publishing
Levinkron O, Schwalb L, Shoufani A, Gutovitz J, Krausz J, Briscoe D (2024) Comparison of the clinical characteristics of benign and malignant eyelid lesions: an analysis of 1423 eyelid lesions, compared between ophthalmology department and plastics department. Graefes Arch Clin Exp Ophthalmol 262(2):615–621. https://doi.org/10.1007/s00417-023-06244-5
Oliveira D et al (2000) Eyelid and conjunctiva epithelial tumors: a review of risk factors and primary prevention options. ARC Journal of Ophthalmology 5(1):21–29
Bianciotto C, Demirci H, Shields CL, Eagle RC, Shields JA (2009) Metastatic tumors to the eyelid: report of 20 cases and review of the literature. ArchOphthalmol 127(8):999–1005. https://doi.org/10.1001/archophthalmol.2009.120
H Rana TJ Stokkermans B Purt et al. Malignant Eyelid Lesions [Updated 2023 Aug 14]. In: StatPearls [Internet] Treasure Island (FL): StatPearls Publishing
Shi Y, Jia R, Fan X (2017) Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment. Onco Targets Ther 10:2483–2489. https://doi.org/10.2147/OTT.S130371
Baş Z, Sharpe J, Yaghy A, Zhang Q, Shields CL, Hyman L, IRIS Registry Analytic Center Consortium (2022) Prevalence of and Associated Factors for Eyelid Cancer in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmol Sci. 3(1):100227
Ul Kadir SM, Rani Mitra M, Rashid R, Nuruddin M, Hassan Khan MK, Haider G, Nessa MS (2022) Clinicopathological analysis and surgical outcome of eyelid malignancies: a study of 332 cases. J Skin Cancer 2022(18):4075668. https://doi.org/10.1155/2022/4075668
Burgic M, Iljazovic E, Vodencarevic AN, Burgic M, Rifatbegovic A, Mujkanovic A, Halilbasic M, Sinanovic M (2019) Clinical characteristics and outcome of malignant eyelid tumors: a five-year retrospective study. Med Arch 73(3):209–212
Yu SS, Zhao Y, Zhao H, Lin JY, Tang X (2018) A retrospective study of 2228 cases with eyelid tumors. Int J Ophthalmol 11(11):1835–1841. https://doi.org/10.18240/ijo.2018.11.16
Rene C (2013) Oculoplastic aspects of ocular oncology. Eye (Lond) 27(2):199–207. https://doi.org/10.1038/eye.2012.243
Mudhar HS, Nuruddin M, Roy SR (2016) Eyelid Metastatic Thyroid Papillary Carcinoma. Ocul Oncol Pathol. 2(3):156–159
Aurora AL, Blodi FC (1970) Lesions of the eyelids: a clinic pathological study. Surv Ophthalmol 15:94–104
Arnold AC, Bullock JD, Foos RY (1985) Metastatic eyelid carcinoma. Ophthalmology 92:114–119
Wang JK, Liao SL, Jou JR et al (2003) Malignant eyelid tumours in Taiwan Eye 17:216–220
Weiner JM, Henderson PN, Roche J (1986) Metastatic eyelid carcinoma. Am J Ophthalmol 101:252–254
Ahmad SM, Esmaeli B (2007) Metastatic tumors of the orbit and ocular adnexa. Curr Opin Ophthalmol 18(5):405–413. https://doi.org/10.1097/ICU.0b013e3282c5077c
Fonseca NL Jr et al (2009) Metastatic eyelid disease associated with primary breast carcinoma: case report. Arq Bras Oftalmol 72(3):390–393. https://doi.org/10.1590/s0004-27492009000300022
Yeung SN et al (2007) Metastatic eyelid disease associated with hepatocellular carcinoma. Can J Ophthalmol 42:752–754
Ramez AM, Hamed M, Saad EA (2022) Metastatic renal cel S. l. carcinoma to the eyelid: an unusual presentation. Journal of Clinical Urology. 15(3):213–216
Dhannawat SS, Sherwood C, Bahadur R (2020) Eyelid metastasis from lung adenocarcinoma. Am J Ophthalmol Case Rep 20:100991. https://doi.org/10.1016/j.ajoc.2020.100991
Esmaeli B et al (2000) Leiomyosarcoma of the esophagus metastatic to the eyelid. Ophthalmic Plast Reconstr Surg 18(2):159–161
Universiy of Michigan. https://histology.medicine.umich.edu/resources/eye#electron-micrographs. Jan 19, 2023.
Hwang JR, Khachemoune A (2023) Lower lip basal cell and squamous cell carcinomas: a reappraisal of the similarities and differences in clinical presentation and management. Arch Dermatol Res 315(2):117–125. https://doi.org/10.1007/s00403-022-02345-z
Cheng CY, Su HJ, Kuo TT (2020) Dermoscopic features and differential diagnosis of sebaceous carcinoma. J Dermatol 47(7):755–762. https://doi.org/10.1111/1346-8138.15384
KA Prickett ML Ramsey 2023 Mohs Micrographic Surgery. [Updated 2023 Jul 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
Martel A, Lassalle S, Picard-Gauci A, Gastaud L, Montaudie H, Bertolotto C, Nahon-Esteve S, Poissonnet G, Hofman P, Baillif S (2021) New Targeted therapies and immunotherapies for locally advanced periocular malignant tumours: towards a new “eye-sparing” paradigm? Cancers (Basel) 13(11):2822. https://doi.org/10.3390/cancers13112822
Pernick N. Anatomy & histology-eyelid. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/eyeeyelidanatomy.html. Accessed October 4th, 2023.
Kato J, Horimoto K, Sato S, Minowa T, Uhara H (2019) Dermoscopy of melanoma and non-melanoma skin cancers. Front Med (Lausanne) 6:180. https://doi.org/10.3389/fmed.2019.00180
Mulay K, Menon V, Lahane S, Sharma M, Honavar SG (2019) Endocrine mucin-producing sweat gland carcinoma (EMPSGC) of the eyelid: Clinicopathologic features, immunohistochemical findings and review of literature. Indian J Ophthalmol 67(8):1374–1377. https://doi.org/10.4103/ijo.IJO_1745_18
Funding
The authors have no financial relationships relevant to this article to disclose.
Author information
Authors and Affiliations
Contributions
AK and MM conceived the idea for the manuscript. MM analyzed the literature and drafted the manuscript. All authors edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mukarram, M., Khachemoune, A. Upper and Lower Eyelid Malignancies: Differences in Clinical Presentation, Metastasis, and Treatment. Arch Dermatol Res 316, 429 (2024). https://doi.org/10.1007/s00403-024-03163-1
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00403-024-03163-1